NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday

Published 07/09/2022, 13:02
Updated 07/09/2022, 13:40
© Reuters.  Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday
C
-
SBUX
-
IXIC
-
SBUB34
-
CTGP34
-
TGTB34
-

  • Citigroup (NYSE:C) raised the price target on Starbucks Corporation (NASDAQ: NASDAQ:SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in pre-market trading.
  • BTIG cut Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) price target from $57 to $48. BTIG analyst Robert Hazlett maintained the stock with a Buy rating. Eiger BioPharmaceuticals shares rose 5% to $6.34 in pre-market trading.
  • Baird boosted IVERIC bio, Inc. (NASDAQ: ISEE) price target from $27 to $34. Baird analyst Colleen Kusy maintained an Outperform rating on the stock. IVERIC bio shares fell 2.2% to $15.36 in pre-market trading.
  • Raymond James cut Newell Brands Inc. (NASDAQ: NWL) price target from $26 to $23. Raymond James analyst Olivia Tong maintained a Strong Buy rating on the stock. Newell Brands shares fell 4.6% to $16.30 in pre-market trading.
  • Deutsche Bank (ETR:DBKGn) boosted Darden Restaurants, Inc. (NYSE: DRI) price target from $124 to $131. Deutsche Bank analyst Brian Mullan maintained the stock with a Hold. Darden fell 1.6% to close at $123.21 on Tuesday.
  • Citigroup raised Coupa Software Incorporated (NASDAQ: COUP) price target from $77 to $82. Citigroup analyst Steven Enders maintained a Buy rating on the stock. Coupa Software shares rose 11.3% to $62.13 in pre-market trading.
Check out this: Market Volatility Rises As US Stocks Start Holiday-Shortened Week On Downbeat Note

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.